|
4NM4
Crystal structure of broadly neutralizing antibody CR8043
Deposited 2013-11-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
115–214(100 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;20% PEG 6000, 0.1 M HEPES pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.65 Å
R-free 0.232
|
|
4NM4
Crystal structure of broadly neutralizing antibody CR8043
Deposited 2013-11-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain M
115–214(100 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;20% PEG 6000, 0.1 M HEPES pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.65 Å
R-free 0.232
|
|
4NM8
Crystal structure of broadly neutralizing antibody CR8043 bound to H3 influenza hemagglutinin
Deposited 2013-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain L
115–214(100 aa)
Chain M
115–214(100 aa)
Chain N
115–214(100 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;2.2 M ammonium sulfate, 0.1 M sodium acetate pH 5.5, 3% PEG 400, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 4.00 Å
R-free 0.292
|
|
5VIC
Crystal structure of anti-Zika antibody Z004 bound to DENV-1 Envelope protein DIII
Deposited 2017-04-14
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
109–214(106 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;295 K;0.1M sodium acetate trihydrate pH 4.5, 30% w/v PEG 1500
|
Resolution 3.00 Å
R-free 0.286
|
|
5VIG
Crystal structure of anti-Zika antibody Z006 bound to Zika virus envelope protein DIII
Deposited 2017-04-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
109–214(106 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;295 K;10% isopropanol, 0.1M sodium citrate tribasic dihydrate pH 5.0, 26% PEG 400
|
Resolution 3.00 Å
R-free 0.257
|
|
5VIG
Crystal structure of anti-Zika antibody Z006 bound to Zika virus envelope protein DIII
Deposited 2017-04-16
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
109–214(106 aa)
|
Not recorded
|
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;295 K;10% isopropanol, 0.1M sodium citrate tribasic dihydrate pH 5.0, 26% PEG 400
|
Resolution 3.00 Å
R-free 0.257
|
|
5W1K
JUNV GP1 CR1-10 Fab CR1-28 Fab complex
Deposited 2017-06-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
109–212(104 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;pH 7.7;297 K;1.9 M AmSO4 pH 7.7
|
Resolution 3.99 Å
R-free 0.288
|
|
5W1K
JUNV GP1 CR1-10 Fab CR1-28 Fab complex
Deposited 2017-06-03
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain F
109–212(104 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;pH 7.7;297 K;1.9 M AmSO4 pH 7.7
|
Resolution 3.99 Å
R-free 0.288
|
|
5W1K
JUNV GP1 CR1-10 Fab CR1-28 Fab complex
Deposited 2017-06-03
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain K
109–212(104 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;pH 7.7;297 K;1.9 M AmSO4 pH 7.7
|
Resolution 3.99 Å
R-free 0.288
|
|
5W1K
JUNV GP1 CR1-10 Fab CR1-28 Fab complex
Deposited 2017-06-03
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain S
109–212(104 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
BATCH MODE;pH 7.7;297 K;1.9 M AmSO4 pH 7.7
|
Resolution 3.99 Å
R-free 0.288
|
|
6BF7
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-E light chain
Deposited 2017-10-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
129–211(83 aa)
Chain F
129–211(83 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.8
cryo-EM vitrification conditions
Cryogen ETHANE;The cryo grids were made using Spotiton
|
Resolution 6.50 Å
|
|
6BF9
Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-E light chain
Deposited 2017-10-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
109–211(103 aa)
Chain F
109–211(103 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.8
cryo-EM vitrification conditions
Cryogen ETHANE;The cryo grids were made using Spotiton
|
Resolution 7.20 Å
|
|
6MSY
Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement
Deposited 2018-10-18
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
109–213(105 aa)
|
Not recorded
|
UNX UNKNOWN LIGAND × 8
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;295 K;27% Peg 4000, 0.05M sodium acetate
|
Resolution 2.00 Å
R-free 0.242
|
|
6MU3
Anti-HIV-1 Fab 2G12 + Man7 re-refinement
Deposited 2018-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain K
110–213(104 aa)
Chain L
110–213(104 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.6;295 K;20% Peg 4000, 0.2M sodium tartrate
|
Resolution 2.33 Å
R-free 0.234
|
|
6MUB
Anti-HIV-1 Fab 2G12 + Man5 re-refinement
Deposited 2018-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain K
110–213(104 aa)
Chain L
110–213(104 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.8;295 K;1.6M sodium/potassium phosphate
|
Resolution 2.50 Å
R-free 0.280
|
|
6N2X
Anti-HIV-1 Fab 2G12 + Man9 re-refinement
Deposited 2018-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain K
109–213(105 aa)
Chain L
109–213(105 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;295 K;25% Peg 400, 0.2M imidazole malate
|
Resolution 3.00 Å
R-free 0.283
|
|
6N32
Anti-HIV-1 Fab 2G12 re-refinement
Deposited 2018-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
109–213(105 aa)
Chain M
109–213(105 aa)
|
Not recorded
|
SO4 SULFATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1.05M ammonium sulfate, 18% Peg 6000, 0.1M imidazole malate
|
Resolution 2.20 Å
R-free 0.227
|
|
6N35
Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement
Deposited 2018-11-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain K
109–213(105 aa)
Chain L
109–213(105 aa)
|
Not recorded
|
BEZ BENZOIC ACID × 1
GOL GLYCEROL × 1
MAN alpha-D-mannopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;2M Sodium/Potassium Phosphate
|
Resolution 1.75 Å
R-free 0.238
|
|
6NQD
Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer in complex with 8ANC195 Fab
Deposited 2019-01-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain D
109–214(106 aa)
Chain H
109–214(106 aa)
Chain L
109–214(106 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 30
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.90 Å
|
|
6UOE
3-25 Fab germline-reversion variant bound to an HCMV gB-derived peptide
Deposited 2019-10-14
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
114–214(101 aa)
|
Not recorded
|
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;0.1 M magnesium chloride, 13.4% PEG3350, 16.75% PEG400, 0.1 M Tris, pH 8.5
|
Resolution 1.80 Å
R-free 0.186
|
|
6UTE
Crystal structure of Z032 Fab in complex with WNV EDIII
Deposited 2019-10-29
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
109–214(106 aa)
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium bromide, 20% w/v polyethylene glycol 3,350
|
Resolution 2.90 Å
R-free 0.264
|
|
6UTE
Crystal structure of Z032 Fab in complex with WNV EDIII
Deposited 2019-10-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
109–214(106 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium bromide, 20% w/v polyethylene glycol 3,350
|
Resolution 2.90 Å
R-free 0.264
|
|
6UTE
Crystal structure of Z032 Fab in complex with WNV EDIII
Deposited 2019-10-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
109–214(106 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium bromide, 20% w/v polyethylene glycol 3,350
|
Resolution 2.90 Å
R-free 0.264
|
|
6UTE
Crystal structure of Z032 Fab in complex with WNV EDIII
Deposited 2019-10-29
|
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
109–214(106 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium bromide, 20% w/v polyethylene glycol 3,350
|
Resolution 2.90 Å
R-free 0.264
|
|
6UTE
Crystal structure of Z032 Fab in complex with WNV EDIII
Deposited 2019-10-29
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain J
109–214(106 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2 M sodium bromide, 20% w/v polyethylene glycol 3,350
|
Resolution 2.90 Å
R-free 0.264
|
|
8BBO
SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab
Deposited 2022-10-14
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
2–214(213 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;2% (v/v) PEG400, 0.1M imidazole pH7.0 and 24% (w/v) PEG MME 5000.
|
Resolution 2.75 Å
R-free 0.252
|
|
8XKJ
Ckappa domain of human immunoglobulin
Deposited 2023-12-23
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
110–213(104 aa)
Fragment:Ckappa domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5;298 K;Ionic strength (raw mmCIF value) Not defined;Pressure 1
NMR sample composition
1.0 mM [U-13C; U-15N] protein, 5 mM Napi, 50 mM sodium chloride, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|